PARIS (AP) – France’s prime well being advisory physique recommends that the AstraZeneca coronavirus vaccine solely be utilized in folks beneath 65, citing a scarcity of adequate information on its effectiveness in older folks.
The choice may shake up the French vaccination technique, as a result of the nation has prioritized nursing dwelling residents and folks over 75. France had counted on the AstraZeneca vaccine for a lot of of its subsequent inoculations, till the corporate introduced delays that have an effect on international locations in Europe and the world.
The French steering differs from that given by the European Medicines Company, which on Friday approved the AstraZeneca vaccine to be used in all adults within the European Union, amid criticism that the bloc just isn’t shifting quick sufficient to vaccinate your inhabitants.
Well being authorities in Germany and different international locations have expressed concern that the Anglo-Swedish firm has not examined the vaccine in sufficient older folks to indicate that it really works for them, and indicated that they’d not advocate it for folks over 65.
In a information issued Tuesday, France’s Excessive Well being Authority stated it “recommends that the vaccine … be ideally administered to folks beneath 65 years of age.” He says he’ll assessment this information when AstraZeneca has extra information on the effectiveness of the vaccine in older folks.
The French authorities depends upon the steering of the Excessive Authority and can announce on Wednesday how this impacts its plans. Well being officers have stated they continuously adapt vaccine technique based mostly on dose availability, demand, and regulatory steering.